Catheter-associated bloodstream infections (CA-BSIs) are a significant cause of morbidity, mortality, and added medical costs to hospitalized adult and pediatric patients. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] According to the National Nosocomial Infection Surveillance System established by the Centers for Disease Control and Prevention (CDC), the pooled mean in 2004 among 54 PICUs was 6.6 CA-BSIs per 1000 catheterdays, higher than in many adult ICUs. 12 More recent estimates that included 36 PICUs have shown a pooled mean rate of 5.3 CA-BSIs per 1000 catheterdays. 13 Despite these data, strategies to reduce health care complications such as pediatric CA-BSIs have received relatively little attention.
CA-BSIs in adult ICUs have been nearly eliminated by applying a multifaceted intervention [14] [15] [16] [17] that is now used broadly throughout the United States and the world. Whether these findings and interventions apply to children is not known.
Children who receive care in PICUs have unique, albeit not thoroughly researched, risk factors for CA-BSIs compared with adult patients. These differences include a less-clear protective effect of central lines in the jugular or subclavian veins, as opposed to the femoral veins, and the presence of underlying genetic syndromes and congenital malformations. [18] [19] [20] In addition, pediatric providers use patient central lines differently. For example, consistent anecdotal reports have shown providers to have a greater reliance on central lines to obtain needed blood samples or to keep the lines in place longer to ensure secure venous access in an emergency. The National Association of Children's Hospitals and Related Institutions (NACHRI) developed a quality-improvement collaborative, composed of 29 PICUs, to identify and test the impact of pediatricspecific catheter-care practices in reducing pediatric CA-BSI rates.
METHODS

Study Design, Setting, Participants, and Objectives
Twenty-seven NACHRI member hospitals agreed to work collaboratively to reduce the CA-BSI rates among their 29 PICUs. The study design was a multiinstitutional, interrupted time-series design that included historical control data from each of the 29 PICUs from January 2004 to August 2006. With a goal of eliminating CA-BSIs attributed to the PICU, the collaborative set interim first-year goals of a 50% decrease in CA-BSI rates by reliably using the collaborative insertion bundle for 90% of central line insertions and by reliably performing the collaborative maintenance bundle for 70% of all central line cathetermaintenance care.
As part of their participation in the collaborative, each team committed a senior PICU leader/physician champion to support and promote the unit team. The 2 to 3 additional team members for each site included quality-improvement leaders, infectious disease physicians, PICU nursing leaders, and/or infection-control professionals. The PICU teams participated in 4 face-to-face learning workshops in the first year, monthly conference calls, and monthly data collection and submission. Each PICU team, using quality-improvement methods of small tests of change, tested and implemented changes to make their care practices commensurate with the collaborative's recommended central line insertion and maintenance-care practices. From October 2006 through September 2007, the teams engaged in intensive efforts to reduce PICU CA-BSI rates by implementing the insertion and maintenance-care bundles. Each PICU team consulted with its respective institutional review board (IRB) regarding collaborative participation and received either IRB approval or a determination that the effort did not need IRB review.
Interventions
Our study involved 2 central line care bundles, one focused on insertion practices and one focused on maintenance practices (Table 1 ). The insertion bundle included evidence-based procedures recommended by the CDC that have been proven to be effective in adult patients or in a single institutional PICU. 16, 21, 22 Contrary to adult CA-BSI efforts, our bundle did not discourage the use of the femoral site, because this can often be the most convenient or optimal insertion site for children, and the evidence of increased infection risk with femoral sites is not definitive for pediatric patients. 12, [23] [24] [25] The maintenance bundle was created by using some of the pertinent CDC guidelines; however, consensus of mostly expert pediatric physicians and nurses from approximately 20 children's institutions were involved in the development of this effort because of the relative paucity of more rigorous evidence on an effective maintenance bundle. 14, 21 
Measures and Data
Data were collected by using insertionbundle and maintenance-bundle compliance as the 2 process measures. Each PICU team self-monitored all central-line insertions that occurred in the PICU and submitted data on compliance with each insertion-bundle element for all of the insertions that occurred each month. Once each week, each PICU team audited all of the central lines to check for compliance with each element of the maintenance bundle. The insertion-bundle and maintenance-bundle audit data were recorded each month by each PICU and entered into the collaborative data-base. Compliance for both bundles was assessed as all or none, meaning that each patient's insertion or maintenance event had to comply with all of the elements of the respective bundle to be considered compliant.
Our outcome measure was the monthly PICU CA-BSI rate, defined as CA-BSI cases per 1000 central-linedays. The number of CA-BSI cases and the monthly total of central-linedays per PICU were collected by trained, hospital-based, infectioncontrol practitioners in accordance with CDC definitions. 21 
Analysis and Interpretation
Monthly and quarterly data pertaining to the CA-BSI collaborative were recorded and analyzed from January To examine the data and account for the clustering effect within the individual PICUs, we used hierarchical modeling including marginal generalized linear models with log-links, negative binomial distributions, and working autoregressive correlation structures. These models were fit by using generalized estimating equations with robust variance estimation. 26 The analytic model allowed the CA-BSI rate to change as a function of time within each period (different temporal slopes within the baseline, ramp-up, and stable-effects periods); the log-link in the generalized linear models implied that exponentiated coefficients were interpreted as relative rates (RRs), which were relative increases or decreases above or below the last quarter's rate, similar to a relative risk. Specifically, the model estimated the RR (increase or decrease) of CA-BSIs per quarter during the baseline period, the RR of CA-BSIs comparing the ramp-up period to the last quarter of the baseline period, and the RR of CA-BSIs per quarter during the stableeffects period. An additional simplified model was examined to estimate a single CA-BSI rate during each of the 3 periods (baseline, ramp-up, and stable-effects) and to compare those rates. The use of the simplified model assuming a single CA-BSI rate during each of the 3 periods was considered acceptable given that within each period, the CA-BSI rate did not significantly change over time. Models were adjusted for geographic region, average length of stay, and bed capacity to account for any unpredicted regional variations in care and to attempt to account for any PICU-specific severity of patient illness. Nonlinear relationships were explored by using the lowess smoothing functions and splines. 27, 28 Hierarchical regression modeling was also used to examine individual compliance effects (either insertion or maintenance) after adjusting for covariables and the alternate compliance variable. 29 Missing data in our analyses were exclusively confined to the baseline precollaborative period (January 2004 to September 2006) and encompassed 18.6% of baseline data. To examine the effects of the missing data, we ran 2 sensitivity analyses models by imputing data for each missing data point. All of the results were similar in estimates and statistical significance to Replace administration sets, including add-on devices, no more frequently than every 72 h unless they are soiled or suspected to be infected. Replace tubing that is used to administer blood, blood products, or lipids within 24 h of initiating infusion. a Change caps no more often than 72 h (or according to manufacturer recommendations); however, caps should be replaced when the administration set is changed. a The prepackaged cap-change kit, or supply area elements to be designated by the local institution. the all-observable analyses reported here. [30] [31] [32] [33] All analyses were conducted by using SAS 9.1 (SAS Institute, Inc, Cary, NC), and statistical process control charts, including U charts, were also used in the preliminary analyses to examine whether the observed differences were a special-cause variation or a common-cause variation. 34 Table 2 provides the characteristics of the 29 pediatric PICUs enrolled in our NACHRI PICU CA-BSI collaborative. Overall, most of the PICUs were mixed pediatric and cardiac PICUs, with 2 being solely pediatric cardiac ICUs. The majority of sites had level 1 trauma centers and performed solid-organ transplants, bone marrow transplants, and extracorporeal membrane oxygenation.
RESULTS
The average baseline CA-BSI rate for the 29 PICUs, in aggregate, was 5.4 CABSIs per 1000 central-line-days. After initiation of the interventions, the rate began to decrease in the ramp-up period (4.3 CA-BSIs per 1000 central-linedays) and decreased to an average stable-effect rate of 3.1 CA-BSIs per 1000 central-line-days. These results translate into a significant difference between the baseline CA-BSI rate and the steady-state stable-effect period CA-BSI rate, with a decrease from 5.4 (95% confidence interval [CI]: 4.5-6.4 -3.1 and 2.4 -4.0, respectively; P Ͻ .0001).
In terms of the stated first-year goals of the NACHRI PICU CA-BSI collaborative, the 29 PICUs achieved a 43% reduction in CA-BSI rates. By the end of the first year, the collaborative came close to achieving the insertion-bundle compliance goal with 84% sustained compliance and met the maintenancebundle compliance goal with 82% sustained compliance.
The 29 PICUS reported 324 CA-BSI events during the 12-month postintervention study period (95 205 total central-line-days.).
We used hierarchical cluster-analysis regression modeling and adjusted for the ICU region and PICU demographics (average length of stay and bed capacity). The only significant predictor of the observed decrease in CA-BSI rates was the collective interventions that were used in this collaborative, namely the insertion and maintenance bundles, during the stable-effect period (RR: 0.57 [95% CI: 0.45-0.74]; P Ͻ .0001). Given the downward trend in CA-BSI rates in the baseline data, a more-stringent sensitivity analysis, assuming that the baseline period CA-BSI rate was actually decreasing as opposed to being constant, was conducted to account for this trend. Nearly identical results were found (RR: 0.618 [95% CI: 0.47-0.82]; P Ͻ .001).
To begin exploring which of the bundles had the greatest influence on the observed CA-BSI rate decrease, Fig 1 shows the lowess smoothing line and 95% CIs of the aggregate data from the 29 PICUS for both precollaborative and collaborative CA-BSI rates, as well as the lowess smoothing lines and 95%
FIGURE 1
Data from 29 PICUs showing the rates of CA-BSIs and insertion and maintenance compliance and 95% CIs in the precollaborative and collaborative periods. CIs of the average compliance with the insertion and maintenance bundles in the collaborative period across all 29 PICUs. It is noteworthy that the apparent wide variation in CA-BSI rates is largely a result of variation in the denominator size among the 29 PICUs, from lows of 60 central-line-days per month to highs of 500 central-line-days per month.
Additional analysis to determine the relative importance of insertionbundle compliance compared with maintenance-bundle compliance was performed by using hierarchical cluster modeling. After adjusting for region and PICU demographics, the only significant predictor of the CA-BSI rate decrease was maintenance-bundle compliance (RR: 0.41 [95% CI: 0.20 -0.85]; P ϭ .017).
DISCUSSION
In this PICU CA-BSI collaborative, we demonstrated that reliably implementing a pediatric-specific central-line insertion bundle and a new pediatric central-line maintenance bundle can achieve and sustain significant decreases in pediatric CA-BSI rates in the PICU setting. In contrast with adult ICU care, maximizing insertion-bundle compliance alone cannot help PICUs eliminate CA-BSIs. Instead, the main drivers for further reducing pediatric CA-BSI rates seem to be issues that surround daily maintenance care for central lines, an attribute of bedside nursing care and practice.
To our knowledge, this study is the first to clearly articulate the differential impact of insertion-related practices versus maintenance-related practices on CA-BSI rates in either adult or pediatric populations. [15] [16] [17] Indeed, researchers have emphasized that practices related solely to the insertion of central lines are able, in adult patients, to significantly reduce CA-BSIs. 15, 16 In our study, the main driver to reduce CABSIs was a care bundle focused on maintenance practices, not on insertion practices.
Our analyses should not be interpreted to mean that evidence-based practices for CVL insertions with children should be abandoned. It is much more likely that the 29 PICUs in this collaborative had already maximized the impact of improving central-line insertion practices in the precollaborative period. For several years now, the health care industry has been extensively focused on insertion practices, and every PICU in our collaborative had already changed many of its insertion-related practices, on the basis of these national pressures, in the precollaborative period. In addition, our data suggest that additional reductions in CA-BSI rates will more likely be achieved by focusing attention on the day-to-day handling of central lines and not by additional work on adherence to evidence-based insertion practices. The data in Fig 1 support this assertion. At the onset of this collaborative, adherence to the ideal insertion practices was already higher than 80%. In contrast, adherence to the ideal maintenance practices at the onset of this collaborative was approximately 65%.
Our study also highlights the importance of multidisciplinary teams to address CA-BSIs and the ideal nature of collaborative models for improving pediatric care. Although nurses are clearly involved in helping to ensure adherence to ideal central-line insertion practices, this nursing role is largely a "double-check" function. In contrast, all of the clinical elements in our maintenance bundle comprise direct nursing behaviors in the day-today care of patients. The relationship between hands-on practices of physicians with insertion and hands-on practices of nurses for the daily care of central lines epitomizes the intertwined team nature of care and the dependence on both disciplines to prevent harm to patients from CA-BSIs. 
